Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Elisabeth Buur Stougaard"'
Autor:
Elisabeth Buur Stougaard, Signe Abitz Winther, Hanan Amadid, Marie Frimodt-Møller, Frederik Persson, Tine Willum Hansen, Peter Rossing
Publikováno v:
PLoS ONE, Vol 16, Iss 7, p e0254859 (2021)
BackgroundGlycocalyx lines the inner surface of the capillary endothelium. Capillaroscopy enables visualization of the sublingual capillaries and measurement of the Perfused Boundary Region (PBR) as an estimate of the glycocalyx. Novel software enabl
Externí odkaz:
https://doaj.org/article/e7ce692a3d864ccc8a88d7b2efce8bfa
Autor:
Jens Christian Laursen, Hatice Isik Mizrak, Huda Kufaishi, Sofie Korsgaard Hecquet, Elisabeth Buur Stougaard, Ninna Hahn Tougaard, Marie Frimodt-Møller, Tine Willum Hansen, Christian Stevns Hansen, Peter Rossing
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 108:99-106
Context Blood oxygen saturation (SpO2) is lower in type 1 diabetes (T1D) compared with nondiabetic controls. Hypoxia (low tissue oxygenation) is thought to be a risk factor for progression of diabetic complications, but it is unknown whether hypoxemi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78cd17ee26bc2f78d1efb7896874f901
https://doi.org/10.1210/clinem/dgac559
https://doi.org/10.1210/clinem/dgac559
Autor:
NINNA H. TOUGAARD, MARIE FRIMODT-MOELLER, HANNE SALMENKARI, ELISABETH BUUR STOUGAARD, ISMO MATTILA, TINE W. HANSEN, CRISTINA LEGIDO-QUIGLEY, SOHVI HÖRKKÖ, CAROL FORSBLOM, PER-HENRIK GROOP, MARKKU LEHTO, PETER ROSSING
Publikováno v:
Diabetes. 71
Background: Fecal calprotectin, a marker of inflammation, is increased in persons with type 1 diabetes (T1D) and kidney disease. This may be explained by a reduction of butyrate-producing bacterial species in the gut. Butyrate supplementation has ben
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f89447aeef367eec24527ab2f41821f3
https://doi.org/10.2337/db22-406-p
https://doi.org/10.2337/db22-406-p
Autor:
ELISABETH BUUR STOUGAARD, PETER L. KRISTENSEN, URD KIELGAST, SR., HENRIK U. ANDERSEN, YASMIN H. HAMID, PETER GÆDE, ESBEN SØNDERGAARD, GRY DØRFLINGER, KAREN K. FJELDBORG, KLAVS W. HANSEN, HENRIK H. THOMSEN, THURAYA AL-IMARI, MICHAEL RØDER, PETER ROSSING, FREDERIK PERSSON
Publikováno v:
Diabetes. 71
Background: The indication for treatment of type 1 diabetes (T1D) with the sodium-glucose cotransporter 2 inhibitor (SGLT2i) dapagliflozin has been withdrawn from the European market likely because of concern for diabetic ketoacidosis (DKA) . We aime
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::96e8f12b78756df6376ab0150935c99c
https://doi.org/10.2337/db22-396-p
https://doi.org/10.2337/db22-396-p
Autor:
Frederik Persson, Marie Frimodt-Moeller, Tine W. Hansen, Signe Abitz Winther, Peter Rossing, Hanan Amadid, Elisabeth Buur Stougaard
Publikováno v:
Diabetes. 70
Background: The glycocalyx lines the inner surface of the capillary endothelium. Capillaroscopy enables visualization of the sublingual capillaries and measurement of the perfused boundary region (PBR) as an estimate of the glycocalyx. Novel software
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8992cfd79064b4d3176dcc95000d81e3
https://doi.org/10.2337/db21-380-p
https://doi.org/10.2337/db21-380-p
Autor:
Elisabeth Buur Stougaard, Hanan Amadid, Esben Søndergaard, Marit Eika Jørgensen, Frederik Persson, peter rossing
Publikováno v:
Capital Region of Denmark
Stougaard, E B, Amadid, H, Søndergaard, E, Jørgensen, M E, Persson, F & Rossing, P 2021, ' SGLT2-hæmmere til type 1-diabetes ', Ugeskrift for Laeger, bind 183, nr. 1, V05200351 . < https://ugeskriftet.dk/videnskab/sglt2-haemmere-til-type-1-diabetes >
Stougaard, E B, Amadid, H, Søndergaard, E, Jørgensen, M E, Persson, F & Rossing, P 2021, ' SGLT2-hæmmere til type 1-diabetes ', Ugeskrift for Laeger, bind 183, nr. 1, V05200351 . < https://ugeskriftet.dk/videnskab/sglt2-haemmere-til-type-1-diabetes >
The sodium-glucose cotransporter 2 inhibitor (SGLT2i) dapagliflozin has been approved for the treatment of Type 1 diabetes (T1D) with significant reductions in HbA1c, weight, total daily insulin dose and significant increase in time in range without
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::b5d2a2e94503521f6148f676101c696b
https://pubmed.ncbi.nlm.nih.gov/33491640
https://pubmed.ncbi.nlm.nih.gov/33491640
Autor:
Elisabeth Buur Stougaard, Peter Damm, Lene Ringholm, Sidse Kjærhus Nørgaard, Elisabeth R. Mathiesen
Publikováno v:
Current diabetes reports. 20(8)
To provide an update on glycemic management of type 1 diabetes during breastfeeding with focus on diet and insulin treatment to prevent hypoglycemia, ketoacidosis, and weight retention. Recommendations for insulin pump settings are given. Women with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::063ed0f0b4c26b925ee74810388245db
https://pubmed.ncbi.nlm.nih.gov/32562097
https://pubmed.ncbi.nlm.nih.gov/32562097